⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FHTX News
Foghorn Therapeutics Inc. Common Stock
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
globenewswire.com
FHTX
FIRSTHABIT Successfully Concludes CES 2026 CHALK AI Math Challenge Once Again and Announces Winners
prnewswire.com
FHTX
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
globenewswire.com
FHTX
Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome
prnewswire.com
ADAP
MRNA
SANA
FHTX
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
prnewswire.com
GTBP
ERAS
FHTX
OABI
RXRX
Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
FHTX
King Abdullah International Medical Research Center and Flagship Pioneering Announce Strategic Partnership to Expand Clinical Research of Novel Medicines in Saudi Arabia
prnewswire.com
MOD
SANA
FHTX
ONCR
TLSA
VALO
INCR
IGRN
LILA
GNRX
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
globenewswire.com
FHTX
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
globenewswire.com
FHTX
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
globenewswire.com
FHTX